BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14973390)

  • 1. Estrogen receptor content in malignant breast tumors in men--a review.
    Olsson H
    J Mammary Gland Biol Neoplasia; 2000 Jul; 5(3):283-7. PubMed ID: 14973390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Breast carcinoma in the man. Current results from the viewpoint of clinic and pathology].
    Prechtel K; Prechtel V
    Pathologe; 1997 Jan; 18(1):45-52. PubMed ID: 9157404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor, progesterone receptor, HER2/neu, P53 and Ki-67 status of male breast carcinomas in Pakistan.
    Jamal S; Mushtaq H; Mubarik A; Malik TM
    Asian Pac J Cancer Prev; 2009; 10(6):1067-70. PubMed ID: 20192585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study.
    Wei JL; Zhang JX; Fu DY
    World J Surg Oncol; 2018 Dec; 16(1):236. PubMed ID: 30558615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA-3 expression in male and female breast cancers: comparison of clinicopathologic parameters and prognostic relevance.
    Gonzalez RS; Wang J; Kraus T; Sullivan H; Adams AL; Cohen C
    Hum Pathol; 2013 Jun; 44(6):1065-70. PubMed ID: 23266442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of distribution of oestrogen and progesterone receptors positivities in breast cancer cases in Benin-City, Nigeria.
    Ugiagbe EE; Obaseki DE; Oluwasola AO; Olu-Eddo AN; Akhiwu WO
    Niger Postgrad Med J; 2012 Mar; 19(1):19-24. PubMed ID: 22430597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
    Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
    Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.
    Zhu X; Ying J; Wang F; Wang J; Yang H
    Breast Cancer Res Treat; 2014 Oct; 147(3):551-5. PubMed ID: 25234844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.
    Kwiatkowska E; Teresiak M; Filas V; Karczewska A; Breborowicz D; Mackiewicz A
    Clin Cancer Res; 2003 Oct; 9(12):4452-9. PubMed ID: 14555518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary mucinous carcinomas of the skin express TFF1, TFF3, estrogen receptor, and progesterone receptors.
    Hanby AM; McKee P; Jeffery M; Grayson W; Dublin E; Poulsom R; Maguire B
    Am J Surg Pathol; 1998 Sep; 22(9):1125-31. PubMed ID: 9737246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Male breast cancer: prognostic factors, diagnosis and treatment: a multi-institutional survey of 95 cases].
    Oger AS; Boukerrou M; Cutuli B; Campion L; Rousseau E; Bussières E; Raro P; Classe JM
    Gynecol Obstet Fertil; 2015 Apr; 43(4):290-6. PubMed ID: 25818033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Primary Tumor Surgery in Stage IV Male Breast Cancer.
    Muzaffar M; Kachare S; Vohra N
    Clin Breast Cancer; 2017 Jun; 17(3):e143-e149. PubMed ID: 27998656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma of the male breast: analysis of prognosis compared with matched female patients.
    Borgen PI; Senie RT; McKinnon WM; Rosen PP
    Ann Surg Oncol; 1997; 4(5):385-8. PubMed ID: 9259964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of 21-Gene Recurrence Scores in Male Breast Cancer in the United States.
    Altman AM; Kizy S; Yuan J; Denbo JW; Jensen EH; Hui JYC; Tuttle TM; Marmor S
    Ann Surg Oncol; 2018 Aug; 25(8):2296-2302. PubMed ID: 29907942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma.
    Riva C; Dainese E; Caprara G; Rocca PC; Massarelli G; Tot T; Capella C; Eusebi V
    Virchows Arch; 2005 Oct; 447(4):695-700. PubMed ID: 16075292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
    Amirifard N; Sadeghi E
    Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Male breast cancer: history, epidemiology, genetic and histopathology].
    Leinung S; Horn LC; Backe J
    Zentralbl Chir; 2007 Oct; 132(5):379-85. PubMed ID: 17907078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Characterization and Mortality From Breast Cancer in Men.
    Massarweh SA; Sledge GW; Miller DP; McCullough D; Petkov VI; Shak S
    J Clin Oncol; 2018 May; 36(14):1396-1404. PubMed ID: 29584547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor-beta expression in human testicular germ cell tumors.
    Pais V; Leav I; Lau KM; Jiang Z; Ho SM
    Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.